Details of the Drug

General Information of Drug (ID: DM7AFJ8)

Drug Name
Diannexin
Indication
Disease Entry ICD 11 Status REF
Myocardial reperfusion injury NB31 Phase 2 [1]
Cross-matching ID
UNII
S5HS95L6CN
DrugBank ID
DB15000
TTD ID
D07FQL

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Annexin A5 (ANXA5) TT2Z83I ANXA5_HUMAN Modulator [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT00615966) Phase 2 Study of the Safety of Diannexin in Kidney Transplant Recipients. U.S. National Institutes of Health.
2 Expression and purification of recombinant human annexin V in Escherichia coli. Prep Biochem Biotechnol. 2000 Nov;30(4):305-12.